University of California, Irvine
- Consultant: Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; National Institutes of Health; NeuTec Pharma Ltd.; NextWave Pharmaceuticals, Inc.; Shire Pharmaceuticals Inc.; Taisho Pharmaceutical Co., Ltd.
- Grant Support: Eunice Kennedy Shriver National Institute of Child Health and Human Development; NextWave Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; PsychoGenics Inc.; Quintiles Transnational Corp.; Rhodes Pharmaceuticals L.P.; Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals); Shire Pharmaceuticals Inc.
- Research Support: Addrenex Pharmaceuticals, Inc.; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
- Speakers Bureau: McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals); Shire Pharmaceuticals Inc.